Brave New World
What are we doing differently now that’s better than before? What do we foresee might be future benefits of new ways of working?
TINA FLATAU | Chief Executive Officer | Biopharma Projects
FLIC GABBAY | Managing Partner | tranScrip
DAVID HAWKINS | Founder and Chief Executive Officer | Remedium Capital
HELEN BARKER | Head of Pharmaceutical Development | Reneo Pharma
SEAN BREEN | Head Public Private Partnerships and Science Policy | Takeda
GRAHAM WYLIE | Chief Executive Officer | MRN